Literature DB >> 25308370

Dipeptidyl peptidase-4 inhibitor sitagliptin significantly reduced hepatitis C virus replication in a diabetic patient with chronic hepatitis C virus infection.

Hidekatsu Yanai1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25308370     DOI： 10.1016/s1499-3872(14)60308-8

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


× No keyword cloud information.
  4 in total

Review 1.  Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C.

Authors:  Andrea Crosignani; Antonio Riva; Silvia Della Bella
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Association between Use of Oral Anti-Diabetic Drugs and the Risk of Sepsis: A Nested Case-Control Study.

Authors:  Chia-Jen Shih; Yueh-Lin Wu; Pei-Wen Chao; Shu-Chen Kuo; Chih-Yu Yang; Szu-Yuan Li; Shuo-Ming Ou; Yung-Tai Chen
Journal:  Sci Rep       Date:  2015-10-14       Impact factor: 4.379

3.  Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors.

Authors:  Cheng-Yi Chen; Vin-Cent Wu; Cheng-Jui Lin; Chih-Sheng Lin; Chi-Feng Pan; Han-Hsiang Chen; Yu-Feng Lin; Tao-Min Huang; Likwang Chen; Chih-Jen Wu
Journal:  Mayo Clin Proc       Date:  2018-10-19       Impact factor: 7.616

4.  Sitagliptin Treatment at the Time of Hospitalization Was Associated With Reduced Mortality in Patients With Type 2 Diabetes and COVID-19: A Multicenter, Case-Control, Retrospective, Observational Study.

Authors:  Sebastiano Bruno Solerte; Francesca D'Addio; Roberto Trevisan; Elisabetta Lovati; Antonio Rossi; Ida Pastore; Marco Dell'Acqua; Elio Ippolito; Cristiana Scaranna; Rosalia Bellante; Silvia Galliani; Alessandro Roberto Dodesini; Giuseppe Lepore; Francesca Geni; Roberta Maria Fiorina; Emanuele Catena; Angelo Corsico; Riccardo Colombo; Marco Mirani; Carlo De Riva; Salvatore Endrio Oleandri; Reza Abdi; Joseph V Bonventre; Stefano Rusconi; Franco Folli; Antonio Di Sabatino; Gianvincenzo Zuccotti; Massimo Galli; Paolo Fiorina
Journal:  Diabetes Care       Date:  2020-09-29       Impact factor: 19.112
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.